Victor Santana Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Victor Santana Santos has a total of 501 co-authors. Here are the top co-authors by number of shared publications:
- Paulo Ricardo Martins-Filho
Investigative Pathology Laboratory, Federal University of Sergipe
50 shared publications - Luis Eduardo Cuevas
Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
21 shared publications - Ricardo Queiroz Gurgel
Universidade Federal de Sergipe, Brasil
18 shared publications - Lucindo J. Quintans-Júnior
Laboratory of Neuroscience and Pharmacological Assays, Federal University of Sergipe, São Cristóvão, SE, Brazil
13 shared publications - Adriano Antunes de Souza Araújo
Federal University of Sergipe
12 shared publications - Carlos Dornels Freire de Souza
Universidade Federal do Vale do São Francisco, Brazil
11 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Elsevier in The Lancet Global Health
- Vol. 14 (11) , 104051
Diagnostic performance and testing costs of pooled testing for molecular detection of tuberculosis in seven countries: a prospective, observational, diagnostic accuracy study
- 24 September 2026
- Published by Elsevier in The Lancet Global Health
- Vol. 14 (11) , 104051
Open AccessDiagnostic performance and testing costs of pooled testing for molecular detection of tuberculosis in seven countries: a prospective, observational, diagnostic accuracy study
- Open Access
- 2 June 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (6)
Sensitivity of Tuberculosis Infection Diagnostic Tests Among Different Populations: A Systematic Review and Meta-analysis
Background: We aimed to estimate the sensitivity of skin and blood–based tuberculosis (TB) infection tests and assess variation in sensitivity by test type and population characteristics. Methods: We conducted a meta-analysis of studies involving individuals with microbiologically confirmed TB disease (surrogate reference standard) who underwent TB infection testing. Searches were performed across databases up to February 24, 2025. Data were extracted using a standardized form and pooled using random-effects meta-analysis. Primary analyses focused on tests performed before or during TB disease treatment. Results: From 103 031 records, 307 studies were included: 110 evaluated tuberculin skin testing (TST), 185 QuantiFERON (QFT), 107 T-SPOT.TB, 10 antigen-based skin tests, and 5 TB-IGRA. Sensitivity was consistently lower among people with HIV. Among populations without vs with HIV, respectively, TST ≥5 mm sensitivity was 80.3% (95% CI, 73.7%–85.5%) and 53.6% (95% CI, 41.5%–65.4%), TST ≥10 mm sensitivity was 75.1% (95% CI, 68.8%–80.5%) and 64.5% (95% CI, 36.8%–85.0%), antigen-based skin test sensitivity was 77.7% (95% CI, 69.7%–84%) and 61.3% (95% CI, 39.6%–79.3%), QFT sensitivity was 82.6% (95% CI, 80.7%–84.3%) and 66.5% (95% CI, 59.8%–72.6%), and T-SPOT.TB sensitivity was 88.2% (95% CI, 86.2%–90.0%) and 69% (95% CI, 56.6%–79.2%). TB-IGRA was only evaluated in populations without HIV (sensitivity, 85.4%; 95% CI, 81.3%–88.7%). Sensitivity in other populations targeted for TB infection testing generally fell between estimates among people with and without HIV. In comparative analyses, TST ≥5 mm and TST ≥10 mm had comparable sensitivity to QFT; however, T-SPOT.TB had superior sensitivity to both TST ≥5 mm and QFT. Conclusions: TB infection test sensitivity varies by test type and population. All tests showed reduced sensitivity in people with HIV. T-SPOT.TB demonstrated the highest sensitivity across populations.
- 2 June 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (6)
Open AccessSensitivity of Tuberculosis Infection Diagnostic Tests Among Different Populations: A Systematic Review and Meta-analysis
Background: We aimed to estimate the sensitivity of skin and blood–based tuberculosis (TB) infection tests and assess variation in sensitivity by test type and population characteristics. Methods: We conducted a meta-analysis of studies involving individuals with microbiologically confirmed TB disease (surrogate reference standard) who underwent TB infection testing. Searches were performed across databases up to February 24, 2025. Data were extracted using a standardized form and pooled using random-effects meta-analysis. Primary analyses focused on tests performed before or during TB disease treatment. Results: From 103 031 records, 307 studies were included: 110 evaluated tuberculin skin testing (TST), 185 QuantiFERON (QFT), 107 T-SPOT.TB, 10 antigen-based skin tests, and 5 TB-IGRA. Sensitivity was consistently lower among people with HIV. Among populations without vs with HIV, respectively, TST ≥5 mm sensitivity was 80.3% (95% CI, 73.7%–85.5%) and 53.6% (95% CI, 41.5%–65.4%), TST ≥10 mm sensitivity was 75.1% (95% CI, 68.8%–80.5%) and 64.5% (95% CI, 36.8%–85.0%), antigen-based skin test sensitivity was 77.7% (95% CI, 69.7%–84%) and 61.3% (95% CI, 39.6%–79.3%), QFT sensitivity was 82.6% (95% CI, 80.7%–84.3%) and 66.5% (95% CI, 59.8%–72.6%), and T-SPOT.TB sensitivity was 88.2% (95% CI, 86.2%–90.0%) and 69% (95% CI, 56.6%–79.2%). TB-IGRA was only evaluated in populations without HIV (sensitivity, 85.4%; 95% CI, 81.3%–88.7%). Sensitivity in other populations targeted for TB infection testing generally fell between estimates among people with and without HIV. In comparative analyses, TST ≥5 mm and TST ≥10 mm had comparable sensitivity to QFT; however, T-SPOT.TB had superior sensitivity to both TST ≥5 mm and QFT. Conclusions: TB infection test sensitivity varies by test type and population. All tests showed reduced sensitivity in people with HIV. T-SPOT.TB demonstrated the highest sensitivity across populations.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 144 (4)
Gender disparities among Brazil's top 2% of influential scientists for career-long impact
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 144 (4)
Open AccessGender disparities among Brazil's top 2% of influential scientists for career-long impact
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 59, e0151
Prevalence of SARS-CoV-2 Infection Among Vulnerable Populations Relying on Public Health Services: Findings from the AVISA Study in Brazil
Background: Understanding SARS-CoV-2 seroprevalence among vulnerable populations is crucial, especially in countries with universal but resource-constrained healthcare systems, such as Brazil. Methods: This was a cross-sectional, population-based household survey within the AVISA study, which aimed to assess seroprevalence among households enrolled in the Family Health Program (ESF). Two serological assays (rapid test and ECLIA) were used to detect anti-SARS-CoV-2 antibodies. Descriptive statistics were calculated and survey-adjusted Poisson regression models with robust variance were estimated, yielding prevalence ratios (PRs) and 95% confidence intervals (CIs). Results: The overall weighted seroprevalence was 35.66% (95% CI: 30.55-40.77) in 2,986 participants. Compared with individuals in the Southeast region, participants in the Northeast and North regions had a 1.48- and 1.38-times higher prevalence of SARS-CoV-2 testing positivity, respectively. Relative to individuals who self-identified as having Black or Brown skin color using IBGE-defined categories, White had a 22% lower prevalence of seropositivity (PR = 0.78, 95% CI 0.63-0.97). Compared to those living in households with four to five family members, individuals living in households with six or more family members had a higher prevalence of seropositivity (PR = 1.34, 95% CI 1.05-1.71). Individuals in the lowest per capita household income quintile were more likely to have SARS-CoV-2 infection (PR = 1.89, 95% CI 1.21-2.95) than those in the highest. Conclusion: This study is the first to assess SARS-CoV-2 seroprevalence among ESF participants, a socioeconomically vulnerable population, served by the primary care public health system. Lower socioeconomic status was associated with higher seroprevalence.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 59, e0151
Open AccessPrevalence of SARS-CoV-2 Infection Among Vulnerable Populations Relying on Public Health Services: Findings from the AVISA Study in Brazil
Background: Understanding SARS-CoV-2 seroprevalence among vulnerable populations is crucial, especially in countries with universal but resource-constrained healthcare systems, such as Brazil. Methods: This was a cross-sectional, population-based household survey within the AVISA study, which aimed to assess seroprevalence among households enrolled in the Family Health Program (ESF). Two serological assays (rapid test and ECLIA) were used to detect anti-SARS-CoV-2 antibodies. Descriptive statistics were calculated and survey-adjusted Poisson regression models with robust variance were estimated, yielding prevalence ratios (PRs) and 95% confidence intervals (CIs). Results: The overall weighted seroprevalence was 35.66% (95% CI: 30.55-40.77) in 2,986 participants. Compared with individuals in the Southeast region, participants in the Northeast and North regions had a 1.48- and 1.38-times higher prevalence of SARS-CoV-2 testing positivity, respectively. Relative to individuals who self-identified as having Black or Brown skin color using IBGE-defined categories, White had a 22% lower prevalence of seropositivity (PR = 0.78, 95% CI 0.63-0.97). Compared to those living in households with four to five family members, individuals living in households with six or more family members had a higher prevalence of seropositivity (PR = 1.34, 95% CI 1.05-1.71). Individuals in the lowest per capita household income quintile were more likely to have SARS-CoV-2 infection (PR = 1.89, 95% CI 1.21-2.95) than those in the highest. Conclusion: This study is the first to assess SARS-CoV-2 seroprevalence among ESF participants, a socioeconomically vulnerable population, served by the primary care public health system. Lower socioeconomic status was associated with higher seroprevalence.
- Open Access
- 17 November 2025
- Vol. 59, e39
Temporal trends and regional clusters of tuberculosis-HIV coinfection outcomes in Brazil.
To investigate the temporal trends and regional clusters of tuberculosis treatment outcomes among people with HIV in Brazil, as well as their relationship with socioeconomic and programmatic indicators. Ecological study with data from people living with HIV who initiated and completed tuberculosis treatment from 2015 to 2021 in Brazil. We described the semiannual trends of cure, treatment interruption, and death rates in Brazilian states using joinpoint regression models. Cluster analyses stratified by three population sizes were conducted using the k-means method to identify clusters in 510 immediate geographic regions. Socioeconomic and programmatic indicators related to treatment interruption and death were included in multivariate negative binomial regression models. A total of 54,362 tuberculosis treatments in people with HIV were analyzed, with cure rates of 55.51%, interruption rates of 23.33%, and death rates of 21.16% for the period. Nationally, cure rates remained stable, while treatment interruption increased by 2.54% per semester (ranging from 1.59% to 3.70%) and death increased by 9.31% (ranging from 7.41% to 17.24%). The states of Ceará and Amapá showed the worst trends for treatment interruption and death. Regions with greater income inequality, higher percentages of workers with only primary education, higher household density, and broader private health coverage had higher rates of treatment interruption and death. Conversely, regions with higher expected years of schooling and hospitalizations for primary care-sensitive conditions had lower probabilities of these outcomes. Nationally, despite stable cure rates, tuberculosis treatment interruption and death among people with HIV increased. Regional disparities in the relationship between socioeconomic and programmatic indicators and outcomes suggest inequities in access to and adherence to tuberculosis treatment across Brazil.
- 17 November 2025
- Vol. 59, e39
Open AccessTemporal trends and regional clusters of tuberculosis-HIV coinfection outcomes in Brazil.
To investigate the temporal trends and regional clusters of tuberculosis treatment outcomes among people with HIV in Brazil, as well as their relationship with socioeconomic and programmatic indicators. Ecological study with data from people living with HIV who initiated and completed tuberculosis treatment from 2015 to 2021 in Brazil. We described the semiannual trends of cure, treatment interruption, and death rates in Brazilian states using joinpoint regression models. Cluster analyses stratified by three population sizes were conducted using the k-means method to identify clusters in 510 immediate geographic regions. Socioeconomic and programmatic indicators related to treatment interruption and death were included in multivariate negative binomial regression models. A total of 54,362 tuberculosis treatments in people with HIV were analyzed, with cure rates of 55.51%, interruption rates of 23.33%, and death rates of 21.16% for the period. Nationally, cure rates remained stable, while treatment interruption increased by 2.54% per semester (ranging from 1.59% to 3.70%) and death increased by 9.31% (ranging from 7.41% to 17.24%). The states of Ceará and Amapá showed the worst trends for treatment interruption and death. Regions with greater income inequality, higher percentages of workers with only primary education, higher household density, and broader private health coverage had higher rates of treatment interruption and death. Conversely, regions with higher expected years of schooling and hospitalizations for primary care-sensitive conditions had lower probabilities of these outcomes. Nationally, despite stable cure rates, tuberculosis treatment interruption and death among people with HIV increased. Regional disparities in the relationship between socioeconomic and programmatic indicators and outcomes suggest inequities in access to and adherence to tuberculosis treatment across Brazil.
- Open Access
- 26 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0330208
Effectiveness of tuberculosis preventive treatment on disease incidence among people living with HIV/AIDS: A systematic review and meta-analysis
Background: Clinical trials have shown the protective efficacy of tuberculosis preventive treatment (TPT) for averting disease and death from tuberculosis among people living with HIV/AIDS (PLHIV). TPT has been recommended for PLHIV since the 1980s. However, tuberculosis is still the first cause of death in PLHIV. Objective: We aimed to summarize the evidence related to the real-world effectiveness of TPT on tuberculosis incidence among PLHIV. Method: This is a systematic review and meta-analysis of observational cohort studies. The search was carried out in PubMed (via MEDLINE), Embase, LILACS, Scopus and Web of Science databases. Free and controlled vocabulary was used for the searches, with no restrictions on language or publication period. Studies reporting hazard ratios (HR) for tuberculosis incidence among PLHIV who received TPT were pooled using random-effects meta-analysis models. Meta-regression was performed to assess whether study-level characteristics accounted for heterogeneity, as evaluated by Cochran’s I² statistic. Study quality was appraised using the Newcastle-Ottawa Scale. This study was registered with PROSPERO (CRD42024586273). Results: Among 8,330 screened studies, 34 were included, with nine contributing to the meta-analysis. TPT was associated with a 63% reduction in tuberculosis incidence risk (HR = 0.37, 95% CI: 0.28–0.48; I² = 43%). Children exhibited consistent stronger protection (82% risk reduction, HR = 0.18, 0.09–0.37; I² = 0%) than adults (56% reduction, HR = 0.44, 0.37–0.53; I² = 21%). Conclusion: In real world conditions, TPT significantly and substantially reduces tuberculosis incidence in PLHIV, with consistent evidence of stronger protective effects in children. Despite some heterogeneity among adult studies, the pooled evidence confirms the protective effectiveness previously observed in clinical trials. These findings reinforce the global recommendation for broad implementation of TPT among PLHIV.
- 26 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0330208
Open AccessEffectiveness of tuberculosis preventive treatment on disease incidence among people living with HIV/AIDS: A systematic review and meta-analysis
Background: Clinical trials have shown the protective efficacy of tuberculosis preventive treatment (TPT) for averting disease and death from tuberculosis among people living with HIV/AIDS (PLHIV). TPT has been recommended for PLHIV since the 1980s. However, tuberculosis is still the first cause of death in PLHIV. Objective: We aimed to summarize the evidence related to the real-world effectiveness of TPT on tuberculosis incidence among PLHIV. Method: This is a systematic review and meta-analysis of observational cohort studies. The search was carried out in PubMed (via MEDLINE), Embase, LILACS, Scopus and Web of Science databases. Free and controlled vocabulary was used for the searches, with no restrictions on language or publication period. Studies reporting hazard ratios (HR) for tuberculosis incidence among PLHIV who received TPT were pooled using random-effects meta-analysis models. Meta-regression was performed to assess whether study-level characteristics accounted for heterogeneity, as evaluated by Cochran’s I² statistic. Study quality was appraised using the Newcastle-Ottawa Scale. This study was registered with PROSPERO (CRD42024586273). Results: Among 8,330 screened studies, 34 were included, with nine contributing to the meta-analysis. TPT was associated with a 63% reduction in tuberculosis incidence risk (HR = 0.37, 95% CI: 0.28–0.48; I² = 43%). Children exhibited consistent stronger protection (82% risk reduction, HR = 0.18, 0.09–0.37; I² = 0%) than adults (56% reduction, HR = 0.44, 0.37–0.53; I² = 21%). Conclusion: In real world conditions, TPT significantly and substantially reduces tuberculosis incidence in PLHIV, with consistent evidence of stronger protective effects in children. Despite some heterogeneity among adult studies, the pooled evidence confirms the protective effectiveness previously observed in clinical trials. These findings reinforce the global recommendation for broad implementation of TPT among PLHIV.
- Open Access
- 22 January 2025
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 13 (1) , e5672
Disparities in leprosy relapse from 2001 to 2022 in Brazil
Objective: to evaluate disparities in leprosy relapse in Brazil from 2001 to 2022. Methods: an ecological time series study was conducted. The ratio of leprosy relapses and new cases was obtained per 10,000, and it was adjusted secondarily according to region, sex, age group, operational classification, and smear microscopy outcomes. The temporal trends were estimated using Prais-Winsten regression analysis, and the comparisons were carried out using Negative Binomial regression. The significance level was adjusted at 5%. Results: the ratio of leprosy relapses per 10,000 new cases was approximately 424, considering 33,198 relapses and 783,704 new cases. The temporal trends were increasing across all Brazilian regions, sexes, operational classifications, and among individuals aged 15 years or older (all p-values <0.05). Stationarity trends were observed among individuals under 15 years (p-value = 0.422) and among smear microscopy outcomes (positive or negative, p-value = 0.147 and 0.156, respectively). Considering the comparison of ratios, significantly higher values were observed in the South region compared to the national estimate, as well as among males, individuals aged 15 years or older, multibacillary cases, and individuals with positive smear microscopy in relation to their respective counterparts (all p-value <0.001). In addition, a significantly lower value was observed in the Central-West region compared to the national estimate (p-value <0.001). Conclusion: in relation to new cases, there was an increase in leprosy relapses from 2001 to 2022 in Brazil, in addition to significant sociodemographic and clinical disparities.
- 22 January 2025
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 13 (1) , e5672
Open AccessDisparities in leprosy relapse from 2001 to 2022 in Brazil
Objective: to evaluate disparities in leprosy relapse in Brazil from 2001 to 2022. Methods: an ecological time series study was conducted. The ratio of leprosy relapses and new cases was obtained per 10,000, and it was adjusted secondarily according to region, sex, age group, operational classification, and smear microscopy outcomes. The temporal trends were estimated using Prais-Winsten regression analysis, and the comparisons were carried out using Negative Binomial regression. The significance level was adjusted at 5%. Results: the ratio of leprosy relapses per 10,000 new cases was approximately 424, considering 33,198 relapses and 783,704 new cases. The temporal trends were increasing across all Brazilian regions, sexes, operational classifications, and among individuals aged 15 years or older (all p-values <0.05). Stationarity trends were observed among individuals under 15 years (p-value = 0.422) and among smear microscopy outcomes (positive or negative, p-value = 0.147 and 0.156, respectively). Considering the comparison of ratios, significantly higher values were observed in the South region compared to the national estimate, as well as among males, individuals aged 15 years or older, multibacillary cases, and individuals with positive smear microscopy in relation to their respective counterparts (all p-value <0.001). In addition, a significantly lower value was observed in the Central-West region compared to the national estimate (p-value <0.001). Conclusion: in relation to new cases, there was an increase in leprosy relapses from 2001 to 2022 in Brazil, in addition to significant sociodemographic and clinical disparities.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e02302025
Determinants of Delayed Leprosy Diagnosis in an Endemic Area of Northeast Brazil: A Cross-Sectional Study
Background: Delayed diagnosis remains a primary challenge in leprosy control, often resulting in severe physical impairment and significant psychological distress among those affected. The factors contributing to this delay are complex and multifactorial, encompassing both patient-related and healthcare system-related elements. To investigate the patient- and health system-related factors contributing to delayed diagnosis of leprosy in an endemic area of Northeast Brazil. Methods: This cross-sectional study included 247 leprosy patients. Demographic and clinical characteristics, along with data on patient- and health system-related determinants associated with delays in diagnosis, were collected. Univariate and multivariate Poisson regression analyses were performed to examine associations between the outcome (delay in months) and the independent variables. Results: The median time from the first healthcare visit to leprosy diagnosis was 15.0 months (interquartile range: 6.0-36.0). Approximately 17% of participants had grade 2 disability (G2D) at diagnosis. In the multivariate Poisson regression analysis, female sex, residence in rural areas, delayed healthcare seeking after symptom onset, lack of initial suspicion of leprosy, multiple referrals requiring four or more consultations before diagnostic confirmation, and prior misdiagnosis with treatment for another condition were independently associated with prolonged diagnostic delay. Conclusion: This study identified significant delays in leprosy diagnosis in Sergipe, Brazil, which may contribute to the persistently high proportion of new cases with G2D. Both patient- and health system-related factors were associated with longer diagnostic delays. Urgent interventions are warranted to increase disease awareness among the general population and strengthen the capacity of primary healthcare services.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e02302025
Open AccessDeterminants of Delayed Leprosy Diagnosis in an Endemic Area of Northeast Brazil: A Cross-Sectional Study
Background: Delayed diagnosis remains a primary challenge in leprosy control, often resulting in severe physical impairment and significant psychological distress among those affected. The factors contributing to this delay are complex and multifactorial, encompassing both patient-related and healthcare system-related elements. To investigate the patient- and health system-related factors contributing to delayed diagnosis of leprosy in an endemic area of Northeast Brazil. Methods: This cross-sectional study included 247 leprosy patients. Demographic and clinical characteristics, along with data on patient- and health system-related determinants associated with delays in diagnosis, were collected. Univariate and multivariate Poisson regression analyses were performed to examine associations between the outcome (delay in months) and the independent variables. Results: The median time from the first healthcare visit to leprosy diagnosis was 15.0 months (interquartile range: 6.0-36.0). Approximately 17% of participants had grade 2 disability (G2D) at diagnosis. In the multivariate Poisson regression analysis, female sex, residence in rural areas, delayed healthcare seeking after symptom onset, lack of initial suspicion of leprosy, multiple referrals requiring four or more consultations before diagnostic confirmation, and prior misdiagnosis with treatment for another condition were independently associated with prolonged diagnostic delay. Conclusion: This study identified significant delays in leprosy diagnosis in Sergipe, Brazil, which may contribute to the persistently high proportion of new cases with G2D. Both patient- and health system-related factors were associated with longer diagnostic delays. Urgent interventions are warranted to increase disease awareness among the general population and strengthen the capacity of primary healthcare services.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 43, e2024298
Vaccination status and main contributors to low vaccination coverage in five health regions in the state of Sergipe
Objective: To measure the percentages of basic pediatric vaccination coverage, of vaccination incompleteness, and to identify their contributors in health regions of the state of Sergipe. Methods: This is a cross-sectional epidemiological study, carried out through home visits to live births (from 2015 to 2021) for data collection, application of a questionnaire and photographic record of the vaccination booklet in health management regions of Sergipe. Results: It was possible to show that health regions present heterogeneity in vaccination coverage, as well as vaccination failure in subsequent doses of multi-dose vaccination schedules. Considering the percentages of vaccination incompleteness and the odds ratios, the health region of Propriá, followed by Estância and Lagarto, had the best percentages. Regarding contributors, in the logistic regression analysis, variables such as fear of a reaction and whether or not a friend/relative advised vaccination were highlighted, considering their significant p-value in the regression analysis. Conclusions: The study provides new results regarding the heterogeneity in vaccination coverage percentages and their contributors in health regions of the state of Sergipe.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 43, e2024298
Open AccessVaccination status and main contributors to low vaccination coverage in five health regions in the state of Sergipe
Objective: To measure the percentages of basic pediatric vaccination coverage, of vaccination incompleteness, and to identify their contributors in health regions of the state of Sergipe. Methods: This is a cross-sectional epidemiological study, carried out through home visits to live births (from 2015 to 2021) for data collection, application of a questionnaire and photographic record of the vaccination booklet in health management regions of Sergipe. Results: It was possible to show that health regions present heterogeneity in vaccination coverage, as well as vaccination failure in subsequent doses of multi-dose vaccination schedules. Considering the percentages of vaccination incompleteness and the odds ratios, the health region of Propriá, followed by Estância and Lagarto, had the best percentages. Regarding contributors, in the logistic regression analysis, variables such as fear of a reaction and whether or not a friend/relative advised vaccination were highlighted, considering their significant p-value in the regression analysis. Conclusions: The study provides new results regarding the heterogeneity in vaccination coverage percentages and their contributors in health regions of the state of Sergipe.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 28, e250012
Temporal and spatial trends of accidents with venomous animal in Brazil before and during the COVID-19 pandemic: a population-based ecological study
Objective: The objective of this study was to analyze the temporal and spatial trends of accidents involving venomous animals in Brazil during the pre- and COVID-19 pandemic periods.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 28, e250012
Open AccessTemporal and spatial trends of accidents with venomous animal in Brazil before and during the COVID-19 pandemic: a population-based ecological study
Objective: The objective of this study was to analyze the temporal and spatial trends of accidents involving venomous animals in Brazil during the pre- and COVID-19 pandemic periods.